Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Saudubray JM, Sedel F, Walter JH. Clinical approach to treatable inborn metabolic diseases: an introduction. J Inherit Metab Dis. 2006;29(2–3):261–74.
Carmody JB, Norwood VF. A clinical approach to paediatric acid-base disorders. Postgrad Med J. 2012;88(1037):143–51.
Kraut JA, Madias NE. Approach to patients with acid-base disorders. Respir Care. 2001;46(4):392–403.
Kraut JA, Madias NE. Differential diagnosis of nongap metabolic acidosis: value of a systematic approach. Clin J Am Soc Nephrol. 2012;7(4):671–9.
Enns GM. Neurologic damage and neurocognitive dysfunction in urea cycle disorders. Semin Pediatr Neurol. 2008;15(3):132–9.
Braissant O, McLin VA, Cudalbu C. Ammonia toxicity to the brain. J Inherit Metab Dis. 2013;36(4):595–612.
Gropman AL, et al. Urea cycle defects and hyperammonemia: effects on functional imaging. Metab Brain Dis. 2013;28(2):269–75.
Gauthier N, et al. A liver-specific defect of Acyl-CoA degradation produces hyperammonemia, hypoglycemia and a distinct hepatic Acyl-CoA pattern. PLoS One. 2013;8(7):e60581.
Coude FX, Sweetman L, Nyhan WL. Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J Clin Invest. 1979;64(6):1544–51.
Baruteau J, et al. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients. J Inherit Metab Dis. 2013;36(5):795–803.
Batshaw ML, et al. Neurologic outcome in premature infants with transient asymptomatic hyperammonemia. J Pediatr. 1986;108(2):271–5.
Saudubray JM, et al. Genetic hypoglycaemia in infancy and childhood: pathophysiology and diagnosis. J Inherit Metab Dis. 2000;23(3):197–214.
Ficicioglu C, et al. Very long-chain acyl-CoA dehydrogenase deficiency in a patient with normal newborn screening by tandem mass spectrometry. J Pediatr. 2010;156(3):492–4.
Sass JO. Inborn errors of ketogenesis and ketone body utilization. J Inherit Metab Dis. 2012;35(1):23–8.
Lamers KJ, et al. The concentration of blood components related to fuel metabolism during prolonged fasting in children. Clin Chim Acta. 1985;152(1–2):155–63.
Bonnefont JP, et al. The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr. 1990;150(2):80–5.
Adeva-Andany M, et al. Comprehensive review on lactate metabolism in human health. Mitochondrion. 2014;17C:76–100.
Adeva M, et al. Enzymes involved in l-lactate metabolism in humans. Mitochondrion. 2013;13(6):615–29.
van den Berghe G. Disorders of gluconeogenesis. J Inherit Metab Dis. 1996;19(4):470–7.
Robinson BH. Lactic acidemia and mitochondrial disease. Mol Genet Metab. 2006;89(1–2):3–13.
Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet. 2006;142C(2):77–85.
Stanley CA. Carnitine deficiency disorders in children. Ann N Y Acad Sci. 2004;1033:42–51.
Santra S, Hendriksz C. How to use acylcarnitine profiles to help diagnose inborn errors of metabolism. Arch Dis Child Educ Pract Ed. 2010;95(5):151–6.
Millington DS, et al. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis. 1990;13(3):321–4.
Van Hove JL, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet. 1993;52(5):958–66.
Rinaldo P, Cowan TM, Matern D. Acylcarnitine profile analysis. Genet Med. 2008;10(2):151–6.
Centerwall WR, Centerwall SA. Phenylketonuria (FOLLING’s disease). The story of its discovery. J Hist Med Allied Sci. 1961;16:292–6.
Guthrie R. Screening for phenylketonuria. Triangle. 1969;9(3):104–9.
Nasset ES, et al. Amino acids in human blood plasma after single meals of meat, oil, sucrose and whiskey. J Nutr. 1979;109(4):621–30.
Goodman SI. An introduction to gas chromatography-mass spectrometry and the inherited organic acidemias. Am J Hum Genet. 1980;32(6):781–92.
Pierpont ME, et al. Myocardial carnitine in end-stage congestive heart failure. Am J Cardiol. 1989;64(1):56–60.
Tuchman M, et al. Mutations and polymorphisms in the human ornithine transcarbamylase gene. Hum Mutat. 2002;19(2):93–107.
Wang J, et al. Targeted array CGH as a valuable molecular diagnostic approach: experience in the diagnosis of mitochondrial and metabolic disorders. Mol Genet Metab. 2012;106(2):221–30.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Coughlin, C.R. (2015). Laboratory Evaluations in Inherited Metabolic Diseases. In: Bernstein, L., Rohr, F., Helm, J. (eds) Nutrition Management of Inherited Metabolic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-14621-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-14621-8_8
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14620-1
Online ISBN: 978-3-319-14621-8
eBook Packages: MedicineMedicine (R0)